Translational Neuroscience in Psychiatry: Light at the End of the Tunnel
Symposium - New York City, United States
Progress developing new and more effective treatments for psychiatric disorders, particularly depression and schizophrenia, has been stymied in part because of a lack of quantitative endpoints (biomarkers) to measure disease progression and response to therapy. Additional factors delaying the development of new drugs include a lack of mechanistic understanding of standard treatments and the complexity, and often long time course, of disease which makes disease modeling in laboratory animals challenging. Fortunately, developments along several fronts are providing new hope for a better understanding of disease progression and tractable mechanisms for drug discovery.
The following topics will be explored in this symposium: progress in validating use of event-related potentials and other electrophysiological means to measure sensory deficits that are increasingly recognized as features of disease pathology; improved methods for brain imaging in patients to monitor illness progression and treatment effect; development of panels of blood biomarkers that reflect ongoing CNS disease pathology.
Organization: New York Academy of Sciences
(Courtesy of the New York City, United States, via nyas.org)
Translational Neuroscience in Psychiatry: Light at the End of the Tunnel
Tuesday, April 8, 2014 (8:30 AM - 4:30 PM)
The New York Academy of Sciences
250 Greenwich St, 40th Floor, New York City, United States
Contact: Diana Friedman (dfriedman@nyas.org)
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.